Characterization of a novel cyclin-dependent kinase 1 inhibitor, BMI-1026.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cancer Research

• Publication date

  2003-11-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  PMID 14612537
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dynamic association of a tumor amplified kinase, Aurora-A, with the centrosome and mitotic spindle.

  2003cited by this paper
• The Cyclin-Ubiquitin Ligase Activity of Cyclosome/APC Is Jointly Activated by Protein Kinases Cdk1-Cyclin B and Plk*

  2002cited by this paper
• A Spindle Checkpoint Arrest and a Cytokinesis Failure by the Dominant-negative Polo-box Domain of Plk1 in U-2 OS Cells* 210

  2002cited by this paper
• Cyclin-dependent kinases as targets for cancer therapy.

  2002cited by this paper
• RESPONSE: re: preclinical and clinical development of cyclin-dependent kinase modulators

  2000cited by this paper
• Preclinical and clinical development of cyclin-dependent kinase modulators.

  2000cited by this paper
• Nuclear Localization of Cyclin B1 Controls Mitotic Entry After DNA Damage

  1998cited by this paper
• Cyclin-dependent kinase inhibitors and human cancer.

  1998cited by this paper
• The Polo-like kinase Plx1 is a component of the MPF amplification loop at the G2/M-phase transition of the cell cycle in Xenopus eggs.

  1998cited by this paper
• PKA and MPF-activated polo-like kinase regulate anaphase-promoting complex activity and mitosis progression.

  1998cited by this paper
• Xe-p9, a Xenopus Suc1/Cks protein, is essential for the Cdc2-dependent phosphorylation of the anaphase- promoting complex at mitosis.

  1998cited by this paper
• Polo-like kinases: a team that plays throughout mitosis.

  1998cited by this paper
• Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation

  1998cited by this paper
• Cyclin-dependent kinases: engines, clocks, and microprocessors.

  1997cited by this paper
• Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine.

  1997influential reference
• Chemical inhibitors of cyclin-dependent kinases.

  1997cited by this paper
• Purification and Molecular Cloning of Plx1, a Cdc25-Regulatory Kinase from Xenopus Egg Extracts

  1996cited by this paper
• Cancer Cell Cycles

  1996cited by this paper
• Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.

  1996influential reference
• Chemical inhibitors of cyclin-dependent kinases.

  1996cited by this paper
• Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase.

  1996influential reference
• Inhibitors of the intracellular Ca(2+)-ATPase in cultured mouse keratinocytes reveal components of terminal differentiation that are regulated by distinct intracellular Ca2+ compartments.

  1995cited by this paper
• Plk is an M-phase-specific protein kinase and interacts with a kinesin-like protein, CHO1/MKLP-1

  1995cited by this paper
• Cell cycle regulation of the activity and subcellular localization of Plk1, a human protein kinase implicated in mitotic spindle function

  1995cited by this paper
• Multiple modes of ligand recognition: Crystal structures of cyclin‐dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenine

  1995influential reference
• Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE

  1994cited by this paper
• Potent inhibition of CDC2 kinase activity by the flavonoid L86-8275.

  1994influential reference
• Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis.

  1993cited by this paper
• Growth inhibition with reversible cell cycle arrest of carcinoma cells by flavone L86-8275.

  1992cited by this paper
• A new screening test for antimitotic compounds using the universal M phase-specific protein kinase, p34cdc2/cyclin Bcdc13, affinity-immobilized on p13suc1-coated microtitration plates.

  1991cited by this paper
• Development of murine epidermal cell lines which contain an activated rasHa oncogene and form papillomas in skin grafts on athymic nude mouse hosts.

  1988cited by this paper

• Cyclin-Dependent Kinase Inhibitor BMI-1026 Induces Apoptosis by Downregulating Mcl-1 (L) and c-FLIP (L) and Inactivating p-Akt in Human Renal Carcinoma Cells

  2021influential citation
• Temperature does matter—an additional dimension in kinase inhibitor development

  2020cites this paper
• Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling

  2017cites this paper
• Bimodal Interaction of Mammalian Polo-Like Kinase 1 and a Centrosomal Scaffold, Cep192, in the Regulation of Bipolar Spindle Formation

  2015cites this paper
• In Silico Molecular Docking and In Vitro Antidiabetic Studies of Dihydropyrimido[4,5-a]acridin-2-amines

  2014cites this paper
• Multiparametric Cell-Based Assay for the Evaluation of Transcription Inhibition by High-Content Imaging

  2013cites this paper
• Genomewide transcription profiles altered by BMI-1026 and Roscovitine and its implication in cellular senescence

  2012cites this paper
• [Research advances in antitumor activities of pyrimidine derivatives].

  2012cites this paper
• Translationally controlled tumor protein induces mitotic defects and chromosome missegregation in hepatocellular carcinoma development

  2012cites this paper
• A Robust High-Content Imaging Approach for Probing the Mechanism of Action and Phenotypic Outcomes of Cell-Cycle Modulators

  2011cites this paper
• Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1

  2011cites this paper
• The Cyclin-Dependent Kinase Inhibitor SCH 727965 (Dinacliclib) Induces the Apoptosis of Osteosarcoma Cells

  2011cites this paper
• Feed-forward mechanism of converting biochemical cooperativity to mitotic processes at the kinetochore plate

  2011influential citation
• Discovery of a novel class of 2-aminopyrimidines as CDK1 and CDK2 inhibitors.

  2011cites this paper
• Cyclin dependent kinase 1 inhibitors: a review of recent progress.

  2011cites this paper
• Discovery and Design of Protein Kinase Inhibitors: Targeting the Cell Cycle in Oncology

  2011cites this paper
• Measuring and interpreting the selectivity of protein kinase inhibitors

  2009cites this paper
• Plk1-dependent and -independent roles of an ODF2 splice variant, hCenexin1, at the centrosome of somatic cells.

  2009cites this paper
• BMI-1026 treatment can induce SAHF formation by activation of Erk1/2.

  2008cites this paper
• Inhibitors of cyclin dependent kinases: useful targets for cancer treatment.

  2008cites this paper
• Pharmacophore Modelling and Virtual Screening for Identification of New Aurora‐A Kinase Inhibitors

  2008cites this paper
• Take Your "M" Time

  2007cites this paper
• Fez1/Lzts1 absence impairs Cdk1/Cdc25C interaction during mitosis and predisposes mice to cancer development.

  2007influential citation
• Polo-like kinase 1 triggers the initiation of cytokinesis in human cells by promoting recruitment of the RhoGEF Ect2 to the central spindle.

  2007cites this paper
• Cyclin B2 suppresses mitotic failure and DNA re-replication in human somatic cells knocked down for both cyclins B1 and B2

  2007cites this paper
• The use of chemical genomics to detect functional systems affecting the non-host disease resistance of pea to Fusarium solani f. sp. phaseoli

  2007cites this paper
• Targeting the cell division cycle in cancer: CDK and cell cycle checkpoint kinase inhibitors.

  2005cites this paper
• Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6.

  2005cites this paper
• Protein Binding Characteristics of 2′-Benzoyloxycinnamaldehyde

  2005cites this paper
• Pyrido[2,3-d]pyrimidin-7-ones as specific inhibitors of cyclin-dependent kinase 4.

  2005cites this paper
• Selective and irreversible cell cycle inhibition by diphenyleneiodonium

  2005cites this paper
• Recent progress in the discovery and development of cyclin-dependent kinase inhibitors

  2005cites this paper
• Inhibition of Cyclin-dependent Kinase 1 Induces Cytokinesis without Chromosome Segregation in an ECT2 and MgcRacGAP-dependent Manner*

  2005cites this paper
• Strategies for the design of potent and selective kinase inhibitors.

  2005cites this paper
• The Use of CDK Inhibitors in Oncology: A Pharmaceutical Perspective

  2004cites this paper
• Cell Cycle Control and Dysregulation Protocols

  2004cites this paper
• Classification of Proliferative Pulmonary Lesions of the Mouse

  2004cites this paper
• The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors.

  2004cites this paper